Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial.
L Bokhari,
L N Jones,
R D Sinclair
RCT
Journal of the European Academy of Dermatology and Venereology : JEADV
2022
19 次引用
PubMed
DOI
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'pmid\u003D34420241';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
简要概述
Oral minoxidil (OM) is potent vasodilator used to treat hypertension androgenetic alopecia and is a pro-drug, activated by hepatic dehydroepiandosterone sulfotransferase (SULT2A1) to minxidil sulfate.
Used In Evidence Reviews
Similar Papers
Annual review of nutrition · 2004
Secular trends in dietary intake in the United States.
664 citations
Journal of the American Academy of Dermatology · 2002
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
372 citations
Journal of the American Academy of Dermatology · 2017
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
343 citations
Current problems in dermatology · 2015
Alopecia areata.
322 citations
Drug design, development and therapy · 2019
Minoxidil and its use in hair disorders: a review.
320 citations
Open Access
Journal of cosmetic dermatology · 2021
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
315 citations
Open Access